WebAggredyne, Inc. Company Profile Houston, TX Competitors, Financials & Contacts - Dun & Bradstreet Find company research, competitor information, contact details & financial … WebThe global platelet aggregation devices market is poised to reach ~$342.4 Million by 2024, growing at a CAGR of 21.0% from 2015 to 2024. Market growth can be attributed to factors such as rising incidence of target diseases, rapid growth in the geriatric population across the globe, technological advancements in platelet aggregometers, and ...
Recall- Software Design Issue Leads to Critical Data Errors
WebBased in Houston, Texas, Aggredyne, Inc. (aggredyne.com) is a privately-held, investor- owned medical device manufacturing and research company, incorporated in 2012. The company, which holds ISO 13485 medical device quality certification, is focused primarily on manufacturing its A-100 AggreGuide® instrument and associated assays for testing ... WebFind company research, competitor information, contact details & financial data for Aggredyne, Inc. of Houston, TX. Get the latest business insights from Dun & Bradstreet. leigh stutchbury
Aggredyne - Crunchbase Company Profile & Funding
WebPay: $79,453.00 - $93,785.00 per year Benefits: Dental insurance Health insurance Health savings account Paid time off Vision insurance Schedule: 8 hour shift Monday to Friday Ability to commute/relocate: Houston, TX 77099: Reliably commute or planning to relocate before starting work (Required) Experience: ISO 13485: 2 years (Preferred) WebAggredyne is a stealth company developing technologies for platelet function testing. Use the CB Insights Platform to explore Aggredyne's full profile. Aggredyne - Products, Competitors, Financials, Employees, Headquarters Locations WebAug 1, 2013 · The AggreGuide A-100 (Aggredyne Inc, Houston, TX; Figure 1) is a new, easy-to-use platelet aggregometer developed to monitor platelet aggregation in whole blood using a laser light–scattering technique. This involves use of an assay cartridge containing arachidonic acid (AA) as the agonist. When whole blood is added to the reaction … leigh stromback